The biosafety and degradability of nanocarriers have always been an important factor restricting their entry into the clinic. In this work, a new nano-system was prepared by coating the photothermal effect of dopamine-doped mesoporous silica nanoparticles with carboxymethyl chitin through electrostatic interaction, and is further anchored with folic acid on the surface for targeted delivery of anti-cancer the drug doxorubicin (DOX). The nano-system (DOX@PDA/MSN-CMCS-FA) is simply modified CMCS after being loaded with DOX and has good dispersibility, and the drug loading is 10.6%. In vitro release studies have shown that the release rate of PDA/MSN-CMCS-FA is 40% in pH 5.5. Effective degradation is debris in 14 d acidic environments. Due to the anti-infrared photothermal effects of PDA doping and DOX chemotherapy, the semi-lethal concentration (IC50) of nanoparticles (NPS) was 14.95 μg/mL, which can inhibit tumor cell growth by photochemical synergistic treatment, and have certain degradation performance.
TheivendranSGuZTangJ, et al.Nanostructured organosilica nitric oxide donors intrinsically regulate macrophage polarization with antitumor effect. ACS Nano2022; 16(7): 10943–10957.
2.
XiangHWuYZhuX, et al.Highly stable silica-coated bismuth nanoparticles deliver tumor microenvironment-responsive prodrugs to enhance tumor-specific photoradiotherapy. J Am Chem Soc2021; 143(30): 11449–11461.
3.
YinHHZhouBGZhaoCK, et al.2D core/shell-structured mesoporous silicene@silica for targeted and synergistic NIR-II-induced photothermal ablation and hypoxia-activated chemotherapy of tumor. Adv Funct Mater2021; 31(24).
4.
ChengYJiaoXFanW, et al.Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics. Biomaterials2020; 256: 120191.
5.
KankalaRKHanYHNaJ, et al.Nanoarchitectured structure and surface biofunctionality of mesoporous silica nanoparticles. Adv Mater2020; 32(23): e1907035.
6.
YangYChenFXuN, et al.Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses. Biomaterials2022; 281: 121368.
7.
CaiZZhangYHeZ, et al.NIR-triggered chemo-photothermal therapy by thermosensitive gold nanostar@mesoporous silica@liposome-composited drug delivery systems. ACS Appl Bio Mater2020; 3(8): 5322–5330.
8.
NiuDJiangYHeJ, et al.Extraction-induced fabrication of yolk-shell-structured nanoparticles with deformable micellar cores and mesoporous silica shells for multidrug delivery. ACS Appl Bio Mater2019; 2(12): 5707–5716.
9.
WangYGouKGuoX, et al.Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers. Acta Biomater2021; 123: 72–92.
10.
YouYHuangKLiuX, et al.Hydrophilic ultralong organic nanophosphors. Small2020; 16(8): e1906733.
11.
HuangXChenLLinY, et al.Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation. Acta Biomater2021; 136: 456–472.
12.
LiqunDJieLXiaoshengZ, et al.BPA-Containing polydopamine nanoparticles for boron neutron capture therapy in a u87 glioma orthotopic model. Adv Funct Mater2023; 33(23): 2214145.
13.
SunJWanZXuJ, et al.Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer. Biomaterials2021; 269: 120629.
14.
HaoMKongCJiangC, et al.Polydopamine-coated Au-Ag nanoparticle-guided photothermal colorectal cancer therapy through multiple cell death pathways. Acta Biomater2019; 83: 414–424.
15.
LiBGongTXuN, et al.Improved stability and photothermal performance of polydopamine-modified Fe(3) O(4) nanocomposites for highly efficient magnetic resonance imaging-guided photothermal therapy. Small2020; 16(45): e2003969.
16.
LiMGuoRWeiJ, et al.Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence. Acta Biomater2021; 136: 546–557.
17.
WuYHuangYTuC, et al.Correction: A mesoporous polydopamine nanoparticle enables highly efficient manganese encapsulation for enhanced MRI-guided photothermal therapy. Nanoscale2022; 14(12): 4770.
18.
LiSGanYLinC, et al.NIR-/pH-Responsive nanocarriers based on mesoporous hollow polydopamine for codelivery of hydrophilic/hydrophobic drugs and photothermal synergetic therapy. ACS Appl Bio Mater2021; 4(2): 1605–1615.
19.
ZhangRYChengKXuanY, et al.A pH/ultrasonic dual-response step-targeting enterosoluble granule for combined sonodynamic-chemotherapy guided via gastrointestinal tract imaging in orthotopic colorectal cancer. Nanoscale2021; 13(7): 4278–4294.
20.
GeigerMStubenrauchKGSamJ, et al.Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody. Nat Commun2020; 11(1): 3196.
21.
ShangMYangHYangR, et al.The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun2021; 12(1): 1940.
22.
WangHDingTGuanJ, et al.Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined. ACS Nano2020; 14(11): 14779–14789.
23.
WangHLinSWangS, et al.Folic acid enables targeting delivery of lipodiscs by circumventing igm-mediated opsonization. Nano Lett2022; 22(16): 6516–6522.
